E Fund Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8M Buy
53,836
+3,378
+7% +$445K 0.15% 74
2026
Q1
$7.03M Buy
+50,458
New +$7.07M 0.21% 67
2025
Q2
$4.94M Sell
44,567
-2,027
-4% -$216K 0.24% 62
2025
Q1
$5.22M Buy
46,594
+14,820
+47% +$1.53M 0.25% 61
2024
Q4
$2.93M Buy
31,774
+3,000
+10% +$270K 0.15% 85
2024
Q3
$2.41M Sell
28,774
-3,670
-11% -$280K 0.12% 81
2024
Q2
$2.23M Buy
32,444
+12,018
+59% +$802K 0.12% 79
2024
Q1
$1.5M Buy
20,426
+111
+0.5% +$8.54K 0.09% 91
2023
Q4
$1.65M Sell
20,315
-569
-3% -$44.3K 0.1% 64
2023
Q3
$1.56M Buy
20,884
+2,480
+13% +$191K 0.12% 59
2023
Q2
$1.42M Sell
18,404
-1,097
-6% -$87.5K 0.11% 59
2023
Q1
$1.62M Sell
19,501
-846
-4% -$70.1K 0.12% 65
2022
Q4
$1.75M Sell
20,347
-4,001
-16% -$317K 0.15% 58
2022
Q3
$1.5M Buy
24,348
+1,044
+4% +$65.8K 0.14% 69
2022
Q2
$1.44M Buy
23,304
+2,448
+12% +$152K 0.13% 72
2022
Q1
$1.24M Buy
20,856
+1,951
+10% +$125K 0.04% 75
2021
Q4
$1.37M Buy
18,905
+368
+2% +$25.3K 0.05% 87
2021
Q3
$1.29M Buy
+18,537
New +$1.3M 0.05% 83
2021
Q1
$1.2M Buy
+18,588
New +$1.2M 0.1% 86

Other funds holding GILD

E Fund Management's GILD Position: Q2 2026 in Review

E Fund Management increased its Gilead Sciences (GILD) stake by 6.7% in Q2 2026, buying an estimated $445K and bringing the position to 53,836 shares worth $6.8M. The position accounts for 0.15% of the portfolio, ranked #74.

E Fund Management first reported a position in GILD in Q1 2021 and has held it in 19 quarters since. The position peaked at $7.03M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • E Fund Management held 53,836 shares of Gilead Sciences worth $6.8M as of Q2 2026.
  • E Fund Management bought 3,378 Gilead Sciences shares in Q2 2026, an estimated $445K.
  • Gilead Sciences made up 0.15% of E Fund Management's portfolio in Q2 2026, its #74 holding.
  • E Fund Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 19 quarters since.
  • E Fund Management's Gilead Sciences position peaked at $7.03M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.